다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
한국임상약학회지 = Korean journal of clinical pharmacy, v.33 no.3, 2023년, pp.153 - 167
진서연 (덕성여자대학교 식품영양학과) , 김효영 (덕성여자대학교 약학과) , 김예슬 (덕성여자대학교 약학과) , 허채원 (덕성여자대학교 약학과) , 권보영 (덕성여자대학교 약학과) , 최보윤 (덕성여자대학교 약학과) , 이보배 (덕성여자대학교 약학과) , 이지예 (덕성여자대학교 약학과) , 권채은 (덕성여자대학교 약학과) , 문영도 (덕성여자대학교 약학과) , (덕성여자대학교 약학과) , 박지현 (덕성여자대학교 약학과)
AI-Helper
Objective: Bipolar disorder displays a spectrum of manifestations, including manic, hypomanic, depressive, mixed, psychotic, and atypical episodes, contributing to its chronic nature and association with heightened suicide risk. Creating effective pharmacotherapy guidelines is crucial for managing b...
Bahk WM, et al. Korean Medication Algorithm Project for Bipolar？Disorder 2022, Fifth Revision: An Executive Summary. Clin？Psychopharmacol Neurosci. 2022;20(4):747-61.
Kwak KP. Bipolar Disorder. Journal of the Korean Medical？Association 2007;50:348.
Kim SJ. Pharmacological Treatment Strategies for Acute Bipolar？Depression. J Korean Neuropsychiatr Assoc 2018; 57(4):287-300.
Health Insurance Review and Assessment S. 'Bipolar disorder' with？severe mood swings, 40% of middle-aged people in their 40s and？50s. Available from https://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID04&MENU_ID0403&page531&CONT_SEQ334226. Accessed August 14, 2023.
Cerimele MJ, Fortney CJ, and Unutzer J. Bipolar Disorder and？Population Health. Psychiatric Services 2017;68(2):192-4.
Kim W, et al. Korean Medication Algorithm Project for Bipolar？Disorder 2022: Overview. J Korean Neuropsychiatr Assoc 2022;61(2):98-109.
American Psychiatric A. Diagnostic and statistical manual of mental？disorders : DSM-5, 5th ed. Arlington VA. 2013.
Goodwin GM, et al. Evidence-based guidelines for treating bipolar？disorder: Revised third edition recommendations from the British？Association for Psychopharmacology. J Psychopharmacol 2016;30(6):495-553.
National Collaborating Centre for Mental H, National Institute for？Health and Care Excellence: Clinical Guidelines, in Bipolar？Disorder: The NICE Guideline on the Assessment and Management？of Bipolar Disorder in Adults, Children and Young People in？Primary and Secondary Care. London: The British Psychological？Society and The Royal College of Psychiatrists, 2014.
Yatham LN, et al. Canadian Network for Mood and Anxiety？Treatments (CANMAT) and International Society for Bipolar？Disorders (ISBD) 2018 guidelines for the management of patients？with bipolar disorder. Bipolar Disord 2018;20(2):97-170.
Malhi GS, et al. The 2020 Royal Australian and New Zealand？College of Psychiatrists clinical practice guidelines for mood？disorders. Australian & New Zealand Journal of Psychiatry 2021;55(1):7-117.
Fountoulakis KN, et al. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar？Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.？Int J Neuropsychopharmacol 2017;20(2):180-95.
Jeong JH, et al. Korean Medication Algorithm Project for Bipolar？Disorder 2022: Comparisons with Other Treatment Guidelines. Clin？Psychopharmacol Neurosci 2023;21(1):32-48.
Korean College of Clinical P. Clinical Pharmacology, Seoul, Shin-il Books, 2022.
Shah N, Grover S, and Rao GP. Clinical Practice Guidelines for？Management of Bipolar Disorder. Indian J Psychiatry 2017;59(Suppl 1):S51-S66.
Woo YS and Bahk W-M. Recent advances in the pharmacotherapy？of psychiatric disorders. jkma 2011;54(10):1061-9.
Jeong JH, et al. Korean Medication Algorithm Project for Bipolar？Disorder 2022: Rapid Cycling. J Korean Neuropsychiatr Assoc 2022;61(3):204-13.
Konstantinou G, et al. Repetitive transcranial magnetic stimulation？(rTMS) in bipolar disorder: A systematic review. Bipolar Disorders 2022;24(1):10-26.
Lin SK. Racial/Ethnic Differences in the Pharmacokinetics of？Antipsychotics: Focusing on East Asians. Journal of Personalized Medicine 2022;12(9):1362.
Zhang X, et al. Association between aripiprazole pharmacokinetics？and CYP2D6 phenotypes: A systematic review and meta-analysis.？Journal of Clinical Pharmacy and Therapeutics 2019;44(2):163-73.
Koopmans AB, et al. Meta-analysis of probability estimates of？worldwide variation of CYP2D6 and CYP2C19. Translational Psychiatry 2021;11(1):141.
Veldic M, et al. Cytochrome P450 2C19 Poor Metabolizer？Phenotype in Treatment Resistant Depression: Treatment and？Diagnostic Implications. Frontiers in Pharmacology 2019;10:83.
Berk M, et al. N-acetyl cysteine for depressive symptoms in bipolar？disorder--a double-blind randomized placebo-controlled trial. Biol Psychiatry 2008;64(6):468-75.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.